DENTSPLY SIRONA Q4 EPS Estimate Lowered by Leerink Partnrs

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Analysts at Leerink Partnrs reduced their Q4 2024 earnings per share estimates for DENTSPLY SIRONA in a report released on Thursday, November 7th. Leerink Partnrs analyst M. Cherny now expects that the medical instruments supplier will earn $0.44 per share for the quarter, down from their prior forecast of $0.58. Leerink Partnrs has a "Hold" rating on the stock. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA's Q1 2025 earnings at $0.40 EPS, Q2 2025 earnings at $0.50 EPS, Q3 2025 earnings at $0.54 EPS, Q4 2025 earnings at $0.54 EPS, FY2025 earnings at $1.98 EPS, FY2026 earnings at $2.32 EPS and FY2027 earnings at $2.60 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. The business had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. DENTSPLY SIRONA's quarterly revenue was up .4% on a year-over-year basis. During the same period in the prior year, the business posted $0.49 earnings per share.

Several other analysts also recently commented on XRAY. Robert W. Baird reduced their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating for the company in a research note on Friday. Needham & Company LLC reduced their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating for the company in a research note on Friday, October 25th. Leerink Partners lowered shares of DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a research note on Thursday. Evercore ISI reduced their price target on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a research report on Tuesday, October 8th. Finally, StockNews.com raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Wednesday, November 6th. Six research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $29.50.

DENTSPLY SIRONA Trading Down 1.2 %

DENTSPLY SIRONA stock traded down $0.21 during trading hours on Monday, reaching $17.65. 5,277,562 shares of the company's stock were exchanged, compared to its average volume of 3,125,136. The company has a quick ratio of 0.87, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The firm's 50 day simple moving average is $24.68 and its 200 day simple moving average is $25.83. The firm has a market capitalization of $3.58 billion, a PE ratio of -8.63, a PEG ratio of 0.97 and a beta of 1.02. DENTSPLY SIRONA has a twelve month low of $17.21 and a twelve month high of $37.60.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently modified their holdings of XRAY. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of DENTSPLY SIRONA by 8.7% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 40,015 shares of the medical instruments supplier's stock valued at $1,328,000 after acquiring an additional 3,219 shares during the last quarter. GSA Capital Partners LLP bought a new position in shares of DENTSPLY SIRONA during the first quarter valued at about $655,000. Texas Permanent School Fund Corp raised its stake in shares of DENTSPLY SIRONA by 4.4% during the first quarter. Texas Permanent School Fund Corp now owns 43,793 shares of the medical instruments supplier's stock valued at $1,453,000 after acquiring an additional 1,863 shares during the last quarter. Envestnet Portfolio Solutions Inc. raised its stake in shares of DENTSPLY SIRONA by 6.6% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 10,748 shares of the medical instruments supplier's stock valued at $357,000 after acquiring an additional 662 shares during the last quarter. Finally, Headlands Technologies LLC raised its stake in shares of DENTSPLY SIRONA by 2,757.4% during the first quarter. Headlands Technologies LLC now owns 24,374 shares of the medical instruments supplier's stock valued at $809,000 after acquiring an additional 23,521 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.